Ballentine Partners, LLC Grifols Sa Transaction History
Ballentine Partners, LLC
- $5.74 Billion
- Q1 2025
A detailed history of Ballentine Partners, LLC transactions in Grifols Sa stock. As of the latest transaction made, Ballentine Partners, LLC holds 10,868 shares of GRFS stock, worth $85,313. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,868Holding current value
$85,313% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding GRFS
# of Institutions
166Shares Held
153MCall Options Held
76.5KPut Options Held
106K-
Brandes Investment Partners, LP La Jolla, CA25.7MShares$202 Million1.99% of portfolio
-
Capital World Investors Los Angeles, CA21.5MShares$169 Million0.03% of portfolio
-
Permian Investment Partners, LP New York, NY18.1MShares$142 Million23.98% of portfolio
-
Black Creek Investment Management Inc. Toronto, A612.7MShares$99.6 Million4.37% of portfolio
-
Armistice Capital, LLC New York, NY9.28MShares$72.8 Million1.01% of portfolio
About Grifols SA
- Ticker GRFS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 678,910,976
- Market Cap $5.33B
- Description
- Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...